Weight Loss Clinic Houston: GLP-1 Options & Genetic Testing

Last reviewed: May 25, 2026

Last updated: May 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Houston's weight loss clinics increasingly offer GLP-1 receptor agonists as evidence-based treatment options. These medications, which work by regulating appetite hormones, have demonstrated clinically significant weight reduction in peer-reviewed studies with response rates varying considerably between individuals.

Choosing the right GLP-1 option requires understanding not just medication types, but also your individual metabolic profile and genetic predispositions. PlexusDx supports this precision-wellness approach by combining compounded GLP-1 medications with optional genetic testing that may help contextualize your pathway responsiveness before beginning treatment.

Understanding GLP-1 Medication Categories Available in Houston

GLP-1 receptor agonists fall into several distinct categories based on formulation and potency. Injectable semaglutide, oral semaglutide, tirzepatide, and emerging dual-action compounds represent different clinical approaches with varying mechanisms and onset profiles.

Houston providers typically discuss both branded and compounded options. Compounded GLP-1 medications from licensed 503A pharmacies offer cost-effective alternatives while maintaining quality standards. Understanding these distinctions helps patients make informed decisions aligned with their clinical needs and financial circumstances.

Clinical Evidence Framework: How GLP-1 Options Compare in Real-World Use

Published trials show GLP-1 medications produce dose-dependent weight reduction, typically 5–22% of baseline body weight depending on medication type, duration, and individual metabolic factors. Titration schedules, injection frequency, and gastrointestinal tolerability differ meaningfully across formulations.

GLP-1 Type	Mechanism	Typical Dose Range	Onset & Frequency
Compounded Semaglutide (Injectable)	GLP-1R agonist; once-weekly dosing	0.25–2.4 mg weekly	Effective within 4–8 weeks; weekly injection
Compounded Oral Semaglutide	GLP-1R agonist; daily oral tablet	7–14 mg daily	Slower onset; requires fasting and proper timing
Compounded Tirzepatide (Injectable)	GLP-1R + GIP agonist; dual-action	2.5–15 mg weekly	Dual-pathway activation; weekly injection
Microdose GLP-1 Protocol	Lower-dose GLP-1R stimulation	0.1–0.5 mg weekly	Minimized GI side effects; gradual onset

Genetic Predispositions and Your Peptide Pathway Response

Individual variation in GLP-1 medication response is partly driven by genetic polymorphisms in appetite-regulation and metabolic pathways. Key variants in the GLP1R gene, GIPR gene, FTO gene, and MC4R gene influence baseline hormone sensitivity and weight-loss trajectory.

PlexusDx's Precision Peptide Genetic Test examines these predisposing variants and may help provide clinical context about your genetic profile in peptide signaling pathways. This information should be interpreted with a qualified healthcare provider to support more personalized treatment conversations, not to predict exact medication response.

Provider Selection and Safety Considerations for Houston Patients

Qualified weight loss providers in Houston should assess cardiovascular history, thyroid function, renal health, and prior medication tolerability before recommending GLP-1 treatment. Contraindications include personal or family history of medullary thyroid cancer and certain diabetic complications.

Reputable clinics conduct baseline labs, establish clear titration schedules, and maintain follow-up monitoring for efficacy and side effects. Ensure your provider partners with licensed 503A compounding pharmacies if pursuing compounded options and has protocols for dose adjustment or medication changes based on individual response.

How PlexusDx Supports a More Personalized Approach

PlexusDx's genetic testing approach contextualizes your individual predispositions in four key peptide-pathway genes: GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These variants may help provide context about baseline hormone sensitivity, though they do not predict exact medication response or guarantee outcomes.

The Precision Peptide Genetic Test ($99 as an add-on or $298 standalone) reveals your genetic predispositions within these pathways—information that should be interpreted with your qualified healthcare provider before starting or adjusting treatment. This test is distinct from pharmacogenomic testing and focuses on pathway biology rather than drug metabolism.

By combining genetic insight with compounded GLP-1 options (semaglutide from $149/mo, tirzepatide from $249/mo, or microdose protocols from $129/month), Houston patients can have more informed conversations with their providers about which formulation and dose schedule may align with their individual biology and clinical goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.